Literature DB >> 5032528

Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus.

J Wahren, P Felig, E Cerasi, R Luft.   

Abstract

Splanchnic and leg exchange of glucose, lactate, pyruvate, and individual plasma amino acids was studied in diabetics 24 hr after withdrawal of insulin and in healthy controls. Measurements were made in the basal postabsorptive state and during the administration of glucose at a rate of 2 mg/kg per min for 45 min. In the basal state, net splanchnic glucose production did not differ significantly between diabetics and controls. However, splanchnic uptake of alanine and other glycogenic amino acids was 1(1/2)-2 times greater in the diabetics, while lactate and pyruvate uptake was increased by 65-115%. Splanchnic uptake of these glucose precursors could account for 32% of hepatic glucose output in the diabetics, as compared to 20% in the controls. This increase in precursor uptake was a consequence of a two- to threefold increment in fractional extraction of these substrates inasmuch as arterial levels of alanine, glycine, and threonine were reduced in the diabetics, while the levels of the remaining substrates were similar in the two groups. Peripheral output of alanine and other glycogenic amino acids as reflected in arterio-femoral venous differences was similar in both groups. An elevation in arterial valine, leucine, and isoleucine was observed in the diabetics, but could not be accounted for on the basis of alterations in splanchnic or peripheral exchange of these amino acids. Administration of glucose (2 mg/kg per min) for 45 min resulted in an 80% reduction in splanchnic glucose output in controls, but failed to inhibit hepatic glucose release in the diabetics despite a twofold greater increment in arterial glucose levels. In both groups no consistent changes in arterial glucagon were observed during the infusion. It is concluded that in nonketotic diabetics (a) total splanchnic output of glucose is comparable to controls, but the relative contribution of gluconeogenesis may be increased by more than 50%; (b) accelerated splanchnic uptake of glucose precursors is a consequence of increased hepatic extraction of available substrates rather than a result of augmented substrate supply; and (c) the failure of glucose infusion to inhibit hepatic glucose output suggests that the exquisite sensitivity of the liver to the infusion of glucose in normal man is a consequence of glucose-induced insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5032528      PMCID: PMC292335          DOI: 10.1172/JCI106989

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  DIABETES, INSULIN, TOLBUTAMIDE, AND GLUCOSE LOAD IN THE DEGRADATION OF C-14-LABELED LACTATE AND PYRUVATE.

Authors:  W W SHREEVE; R C DEMEUTTER; Y SHIGETA
Journal:  Diabetes       Date:  1964 Nov-Dec       Impact factor: 9.461

Review 2.  Role of free fatty acids in glucose homeostasis.

Authors:  N B Ruderman; C J Toews; E Shafrir
Journal:  Arch Intern Med       Date:  1969-03

3.  Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

Authors:  W A Müller; G R Faloona; E Aguilar-Parada; R H Unger
Journal:  N Engl J Med       Date:  1970-07-16       Impact factor: 91.245

4.  Glucose metabolism during leg exercise in man.

Authors:  J Wahren; P Felig; G Ahlborg; L Jorfeldt
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

5.  Amino acid metabolism during prolonged starvation.

Authors:  P Felig; O E Owen; J Wahren; G F Cahill
Journal:  J Clin Invest       Date:  1969-03       Impact factor: 14.808

6.  Plasma amino acid levels and insulin secretion in obesity.

Authors:  P Felig; E Marliss; G F Cahill
Journal:  N Engl J Med       Date:  1969-10-09       Impact factor: 91.245

7.  Arterio-hepatic venous differences of free fatty acids and amino acids. Studies in patients with diabetes or essential hypercholesterolemia, and in healthy individuals.

Authors:  A Carlsten; B Hallgren; R Jagenburg; A Svanborg; L Werkö
Journal:  Acta Med Scand       Date:  1967-02

8.  Control of the levels of free amino acids in plasma by the liver.

Authors:  H Schimassek; W Gerok
Journal:  Biochem Z       Date:  1965-12-31

9.  STUDIES OF THE ROLE OF THE LIVER IN HUMAN CARBOHYDRATE METABOLISM BY THE VENOUS CATHETER TECHNIC. II. PATIENTS WITH DIABETIC KETOSIS, BEFORE AND AFTER THE ADMINISTRATION OF INSULIN.

Authors:  P K Bondy; W L Bloom; V S Whitner; B W Farrar
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

10.  Glucose dynamics in normal subjects and diabetic patients before and after a glucose load.

Authors:  N Forbath; G Hetenyi
Journal:  Diabetes       Date:  1966-11       Impact factor: 9.461

View more
  74 in total

Review 1.  Insulin Regulation of Proteostasis and Clinical Implications.

Authors:  Haleigh A James; Brian T O'Neill; K Sreekumaran Nair
Journal:  Cell Metab       Date:  2017-07-14       Impact factor: 27.287

2.  Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus.

Authors:  J Wahren; L Hagenfeldt; P Felig
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  The variable hyponatremic response to hyperglycemia.

Authors:  S M Moran; R L Jamison
Journal:  West J Med       Date:  1985-01

4.  Separation of physiological factors influencing glucose-insulin kinetics in diabetic patients.

Authors:  B G Min; E J Woo; H K Lee; H K Min
Journal:  Ann Biomed Eng       Date:  1985       Impact factor: 3.934

5.  Gluconeogenesis and the protection of hepatic intracellular pH during diabetic ketoacidosis in rats.

Authors:  J S Beech; S R Williams; R D Cohen; R A Iles
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

Review 6.  Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes.

Authors:  Ashot Sargsyan; Mark A Herman
Journal:  Curr Diab Rep       Date:  2019-08-03       Impact factor: 4.810

7.  2-Aminoadipic acid is a biomarker for diabetes risk.

Authors:  Thomas J Wang; Debby Ngo; Nikolaos Psychogios; Andre Dejam; Martin G Larson; Ramachandran S Vasan; Anahita Ghorbani; John O'Sullivan; Susan Cheng; Eugene P Rhee; Sumita Sinha; Elizabeth McCabe; Caroline S Fox; Christopher J O'Donnell; Jennifer E Ho; Jose C Florez; Martin Magnusson; Kerry A Pierce; Amanda L Souza; Yi Yu; Christian Carter; Peter E Light; Olle Melander; Clary B Clish; Robert E Gerszten
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

8.  Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.

Authors:  L Saccà; M Cicala; B Trimarco; B Ungaro; C Vigorito
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

9.  Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis.

Authors:  O E Owen; F A Reichle; M A Mozzoli; T Kreulen; M S Patel; I B Elfenbein; M Golsorkhi; K H Chang; N S Rao; H S Sue; G Boden
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

10.  Alterations in alanine metabolism in diabetic dogs during short-term treatment with an artificial B cell.

Authors:  E J Freyse; U Fischer; G Albrecht; E Salzsieder
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.